Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 7, 2013, Pages 593-600

  Li, Qun ^a,b,c   Laumonnier, Yves ^c,d   Syrovets, Tatiana ^c   Simmet, Thomas ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

CCL20; CCR6; macrophages; plasmin; signaling; Th17

Indexed keywords

CCL20 PROTEIN, HUMAN; CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR6; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; PLASMIN;

ARTICLE; CCL20; CCR6; CELL CULTURE; DRUG EFFECT; HUMAN; MACROPHAGE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNALING; TH17; TH17 CELL;

CCL20; CCR6; MACROPHAGES; PLASMIN; SIGNALING; TH17;

CELLS, CULTURED; CHEMOKINE CCL20; FIBRINOLYSIN; HUMANS; MACROPHAGES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, CCR6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH17 CELLS;

EID: 84879978671     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt049     Document Type: Article

References (41)

1. Syrovets T, Lunov O and Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol 2012, 92: 509-519.
2. Syrovets T and Simmet T. Novel aspects and new roles for the serine protease plasmin. Cell Mol Life Sci 2004, 61: 873-885.
3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352: 1685-1695.
4. Burysek L, Syrovets T and Simmet T. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem 2002, 277: 33509-33517.
5. Li X, Syrovets T, Genze F, Pitterle K, Oberhuber A, Orend KH and Simmet T. Plasmin triggers chemotaxis of monocyte-derived dendritic cells through an Akt2-dependent pathway and promotes a T-helper type-1 response. Arterioscler Thromb Vasc Biol 2010, 30: 582-590.
6. Li Q, Laumonnier Y, Syrovets T and Simmet T. Plasmin triggers cytokine induction in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 2007, 27: 1383-1389.
7. Li X, Syrovets T and Simmet T. The serine protease plasmin triggers expression of the CC-chemokine ligand 20 in dendritic cells via Akt/NF-kappaB-dependent pathways. J Biomed Biotechnol 2012, 2012: 186710.
8. Leclercq A, Houard X, Loyau S, Philippe M, Sebbag U, Meilhac O and Michel JB. Topology of protease activities reflects atherothrombotic plaque complexity. Atherosclerosis 2007, 191: 1-10.
9. Brands-Nijenhuis AV, van Geel PP and Meijer K. Acute myocardial ischemia in a patient with heterozygous alpha-2-plasmin inhibitor deficiency. Blood Coagul Fibrinolysis 2009, 20: 599-600.
10. Ploplis VA, French EL, Carmeliet P, Collen D and Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 1998, 91: 2005-2009.
11. Shi C and Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011, 11: 762-774.
12. Tedgui A and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86: 515-581.
13. Weber C and Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011, 17: 1410-1422.
14. Zimmerman NP, Vongsa RA, Wendt MK and Dwinell MB. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis 2008, 14: 1000-1011.
15. Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M and Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci 2009, 14: 540-551.
16. Schutyser E, Struyf S, Menten P, Lenaerts JP, Conings R, Put W and Wuyts A, et al. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells. J Immunol 2000, 165: 4470-4477.
17. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB and Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3alpha. J Immunol 1999, 162: 186-194.
18. Arima Y, Harada M, Kamimura D, Park JH, Kawano F, Yull FE and Kawamoto T, et al. Regional neural activation defines a gateway for auto-reactive T cells to cross the blood-brain barrier. Cell 2012, 148: 447-457.
19. Tesmer LA, Lundy SK, Sarkar S and Fox DA. Th17 cells in human disease. Immunol Rev 2008, 223: 87-113.
20. Li Q, Ke F, Zhang W, Shen X, Xu Q, Wang H and Yu XZ, et al. Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. PLoS ONE 2011, 6: e16483.
21. Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, Koga K and Yoshino O, et al. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology 2010, 151: 5468-5476.
22. Buchele B and Simmet T. Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chro-matography and photodiode array detection. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 795: 355-362.
23. Colognato R, Slupsky JR, Jendrach M, Burysek L, Syrovets T and Simmet T. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 2003, 102: 2645-2652.
24. Laumonnier Y, Syrovets T, Burysek L and Simmet T. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood 2006, 107: 3342-3349.
25. Christopherson K and Hromas R, 2nd. Chemokine regulation of normal and pathologic immune responses. Stem Cells 2001, 19: 388-396.
26. Syrovets T, Buchele B, Krauss C, Laumonnier Y and Simmet T. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases. J Immunol 2005, 174: 498-506.
27. Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, Pappu B and Martin-Orozco N, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol 2008, 181: 8391-8401.
28. Cozen AE, Moriwaki H, Kremen M, DeYoung MB, Dichek HL, Slezicki KI and Young SG, et al. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death. Circulation 2004, 109: 2129-2135.
29. Stoneman V, Braganza D, Figg N, Mercer J, Lang R, Goddard M and Bennett M. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ Res 2007, 100: 884-893.
30. Schutyser E, Struyf S and Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003, 14: 409-426.
31. Hromas R, Gray PW, Chantry D, Godiska R, Krathwohl M, Fife K and Bell GI, et al. Cloning and characterization of exodus, a novel beta-chemokine. Blood 1997, 89: 3315-3322.
32. Power CA, Church DJ, Meyer A, Alouani S, Proudfoot AE, Clark-Lewis I and Sozzani S, et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med 1997, 186: 825-835.
33. Hausmann M, Bataille F, Spoettl T, Schreiter K, Falk W, Schoelmerich J and Herfarth H, et al. Physiological role of macrophage inflammatory protein-3 alpha induction during maturation of intestinal macrophages. J Immunol 2005, 175: 1389-1398.
34. Nakanishi T, Takahashi K, Hosokawa Y, Adachi T, Nakae H and Matsuo T. Expression of macrophage inflammatory protein 3a in human inflamed dental pulp tissue. J Endod 2005, 31: 84-87.
35. Ghadjar P, Rubie C, Aebersold DM and Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer 2009, 125: 741-745.
36. Wan W, Lim JK, Lionakis MS, Rivollier A, McDermott DH, Kelsall BL and Farber JM, et al. Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice. Circ Res 2011, 109: 374-381.
37. Yilmaz A, Lipfert B, Cicha I, Schubert K, Klein M, Raithel D and Daniel WG, et al. Accumulation of immune cells and high expression of chemo-kines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques. Exp Mol Pathol 2007, 82: 245-255.
38. Pramanik R, Qi X, Borowicz S, Choubey D, Schultz RM, Han J and Chen G. p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J Biol Chem 2003, 278: 4831-4839.
39. Ambrosino C, Iwata T, Scafoglio C, Mallardo M, Klein R and Nebreda AR. TEF-1 and C/EBPbeta are major p38alpha MAPK-regulated transcription factors in proliferating cardiomyocytes. Biochem J 2006, 396: 163-172.
40. Reibman J, Hsu Y, Chen LC, Bleck B and Gordon T. Airway epithelial cells release MIP-3a/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 2003, 28: 648-654.
41. Sugita S, Kohno T, Yamamoto K, Imaizumi Y, Nakajima H, Ishimaru T and Matsuyama T. Induction of macrophage-inflammatory protein-3a gene expression by TNF-dependent NF-kB activation. J Immunol 2002, 168: 5621-5628.